These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hypertension in obese patients: Pathophysiology and management]. Girerd X; Hansel B Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604 [TBL] [Abstract][Full Text] [Related]
4. The treatment of hypertension in obese patients. Wofford MR; Smith G; Minor DS Curr Hypertens Rep; 2008 Apr; 10(2):143-50. PubMed ID: 18474182 [TBL] [Abstract][Full Text] [Related]
5. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Reisin E; Jack AV Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502 [TBL] [Abstract][Full Text] [Related]
6. [Obesity-related hypertension]. Dorresteijn JA; Visseren FL; van den Meiracker AH; Spiering W Ned Tijdschr Geneeskd; 2011; 154():A1945. PubMed ID: 21418695 [TBL] [Abstract][Full Text] [Related]
7. Progress and controversies: treating obesity and insulin resistance in the context of hypertension. McGill JB; Haffner S; Rees TJ; Sowers JR; Tershakovec AM; Weber M J Clin Hypertens (Greenwich); 2009 Jan; 11(1):36-41. PubMed ID: 19125857 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and treatment of the obesity-related arterial hypertension. Kolanowski J Acta Clin Belg Suppl; 1992; 14():18-25. PubMed ID: 1604957 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of hypertension in obesity]. Scholze J; Sharma AM Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801 [TBL] [Abstract][Full Text] [Related]
11. [Therapy of obesity-associated hypertension]. Scholze J; Patschan S; Dörffel Y; Hansen A Dtsch Med Wochenschr; 2005 Nov; 130(46):2645-50. PubMed ID: 16281161 [TBL] [Abstract][Full Text] [Related]
12. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888 [TBL] [Abstract][Full Text] [Related]
13. Clinical management of the obese hypertensive patient. Frohlich ED Cardiol Rev; 2002; 10(3):127-38. PubMed ID: 12047791 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of obesity-related hypertension]. Skoczylas A Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491 [TBL] [Abstract][Full Text] [Related]
16. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ; Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673 [TBL] [Abstract][Full Text] [Related]
17. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Blumenthal JA; Sherwood A; Gullette EC; Babyak M; Waugh R; Georgiades A; Craighead LW; Tweedy D; Feinglos M; Appelbaum M; Hayano J; Hinderliter A Arch Intern Med; 2000 Jul; 160(13):1947-58. PubMed ID: 10888969 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hypertension in the patients with obesity]. Hano T; Nishio I Nihon Rinsho; 2001 May; 59(5):973-7. PubMed ID: 11392001 [TBL] [Abstract][Full Text] [Related]
19. [Obesity as a risk factor in the development of hypertensive organ damage]. Hano T; Nishio I Nihon Rinsho; 2004 Mar; 62 Suppl 3():87-91. PubMed ID: 15171347 [No Abstract] [Full Text] [Related]